White House lays out effort against animal sedative xylazine but doesn't call for new restrictions

abcnews.go.com:

Federal officials are calling for more testing and research on xylazine, the powerful animal sedative that’s spreading through the nation’s illicit drug supply

WASHINGTON — Federal officials on Tuesday called for more testing and research on xylazine, the powerful animal sedative that’s spreading through the nation’s illicit drug supply, but they stopped short of recommending new restrictions on the veterinary medication.

A six-point plan from the White House's drug control office aims to scale up testing, treatment and efforts to intercept illegal shipments of xylazine, which is being mixed into fentanyl and other illicit opioids.

The White House declared xylazine-laced fentanyl an “emerging threat” in April and called for a national strategy to combat its use. Xylazine, sometimes known as tranq, can cause breathing and heart rates to fall to dangerous levels when used in humans. When injected it can cause large open sores and infections, sometimes leading to amputation.

In the report released Tuesday, drug czar Dr. Rahul Gupta said administration officials will “explore” making xylazine a scheduled drug, subject to regulatory restrictions similar to opioids and amphetamines.

While some states have already scheduled the drug, those efforts have faced pushback from veterinarians, farmers and others who regularly work with it. Federal scheduling limits how drugs can be prescribed, dispensed and stored. Several bills in Congress aim to tighten use of xylazine without limiting its legitimate use in sedating horses, sheep and other animals.

The bulk of the White House’s plan focuses on improving how use of the drug is tracked and treated by health professionals.

“We need more testing to get a national picture of the threat,”